Stocks · Consumer Defensive · Household & Personal Products
Nu Skin Enterprises, Inc. NUS
$4.61 +1.32% Close, Oct 2, 2026 · NYSE · Market cap $223.8M
Weak trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-4.47, down 322.5% year over year.
- Over the past year the stock returned -61.6%, behind the S&P 500 by 76.7 percentage points.
- The stock is 61% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Consumer Defensive sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 7%
- EPS growth (TTM, YoY)Bottom 4%
- FCF growth (TTM, YoY)Bottom 10%
- Revenue growth, 3-year CAGRBottom 4%
- Revenue growth accelerationBottom 28%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 16%
- Gross marginTop 8%
- Operating marginBottom 17%
- Accruals (lower is better)Top 6%
- Net debt / EBITDA (lower is better)Top 48%
- Interest coverBottom 15%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 3%
- Free-cash-flow yieldBottom 42%
- EBITDA / enterprise valueTop 14%
- Sales / enterprise valueTop 4%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 5%
- 6-month returnBottom 6%
- 1-year return vs S&P 500Bottom 5%
- Distance from 52-week highBottom 8%
- Trend checklist (0–4)Bottom 22%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 24%
- Consecutive EPS beatsBottom 15%
- Share of analysts rating BuyBottom 1%
- Upside to consensus price targetTop 6%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 40%
- Maximum drawdown, 3 yearsBottom 12%
- Beta vs S&P 500 (lower is better)Bottom 12%
- Net debt / EBITDA (lower is better)Top 48%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | -14.2% | -15.4% | ↓ |
| Gross margin | 67.2% | 69.2% | ↑ |
| Operating margin | -0.9% | -0.6% | ↑ |
| FCF margin | 3.6% | 0.8% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | -15.4% | -14.2% | ↓ | Bottom 7% |
| EPS growth (TTM, YoY) | -322.5% | — | Bottom 4% | |
| Gross margin | 69.2% | 67.2% | ↑ | Top 8% |
| Operating margin | -0.6% | -0.9% | ↑ | Bottom 17% |
| Net margin | -15.7% | 6.2% | ↓ | — |
| Free-cash-flow margin | 0.8% | 3.6% | ↓ | — |
| Return on invested capital | -1.0% | — | Bottom 16% | |
| Revenue growth, 3-year CAGR | -12.6% | — | Bottom 4% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -23.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.0%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -2.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 1.88×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -0.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 5.21%
- Net buyback yield (TTM)
- 7.96%
- Shareholder yield
- 13.17%
- Share count change, 1 year
- -1.8%
- Share count change, 3-year CAGR
- -1.1%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- +0.8%
- Average 2-day reaction, last 8
- -1.1%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $11.00
- Target vs current price
- +138.6%
- Analysts with a rating
- 11
- Share rating Buy or Strong Buy
- 0%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +0.0% | -6.2% | -12.6% | -11.8% | — |
| May 7, 2026 | -6.7% | -4.4% | -14.4% | -27.5% | -29.7% |
| Feb 12, 2026 | -3.3% | +0.4% | -14.8% | -30.1% | -29.6% |
| Nov 6, 2025 | +13.3% | -2.3% | -13.4% | -11.5% | -6.9% |
| Aug 7, 2025 | +72.0% | -4.4% | +34.5% | +43.4% | +23.8% |
| May 8, 2025 | +53.3% | +7.1% | +27.3% | +35.3% | +44.9% |
| Feb 13, 2025 | +58.3% | +1.6% | +22.3% | +24.4% | +8.2% |
| Nov 7, 2024 | -15.0% | -0.5% | +15.4% | +18.7% | -0.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | $0.20 | $0.20 | +0.0% | $320.1M |
| May 7, 2026 | $0.14 | $0.15 | -6.7% | $320.6M |
| Feb 12, 2026 | $0.29 | $0.30 | -3.3% | $370.3M |
| Nov 6, 2025 | $0.34 | $0.30 | +13.3% | $364.2M |
| Aug 7, 2025 | $0.43 | $0.25 | +72.0% | $386.1M |
| May 8, 2025 | $0.23 | $0.15 | +53.3% | $364.5M |
| Feb 13, 2025 | $0.38 | $0.24 | +58.3% | $445.6M |
| Nov 7, 2024 | $0.17 | $0.20 | -15.0% | $430.1M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (forward) | 5.6× | — | — | — |
| EV / EBITDA | 7.6× | — | — | Top 14% |
| EV / Sales | 0.22× | — | — | Top 4% |
| Free-cash-flow yield | 4.82% | — | — | Bottom 42% |
| Earnings yield | -97.02% | — | — | Bottom 3% |
P/E over the past five years
Range 2.6× – 76.8× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -61.6%
- Earnings per share growth (TTM)
- -322.5%
- Change in P/E multiple
- -91.5%
Most of the move came from a change in the valuation multiple.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.9%
- 200-day average slope (20 days)
- -7.1%
- Distance from 50-day average
- -4.9%
- Distance from 200-day average
- -33.4%
- RSI (14)
- 45.0
- Relative volume
- 0.71×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 40.9%
- Volatility vs own 5-year history
- 39th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.32
- Correlation with S&P 500
- 0.36
- Current drawdown from 1-year high
- -60.7%
- Maximum drawdown, 3 years
- -79.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 10, 2021 | Sep 30, 2026 | -92.8% | 1415 days | Not yet recovered |
| Oct 2, 2020 | Nov 9, 2020 | -16.6% | 26 days | 38 days (Jan 5, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $223.8M
- EPS, diluted (TTM)
- -$4.47
- Revenue (TTM)
- $1.38B
- Dividend yield
- 5.21%
- 52-week range
- $4.45 – $12.04
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $2.70B | $2.23B | $1.97B | $1.73B | $1.49B |
| Gross profit | $2.02B | $1.59B | $1.36B | $1.18B | $1.03B |
| Operating income | $234.0M | $110.8M | $48.3M | -$151.6M | $90.9M |
| Net income | $147.3M | $104.8M | $8.6M | -$146.6M | $160.2M |
| EPS (diluted) | $2.86 | $2.07 | $0.17 | -$2.95 | $3.18 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $430.1M | $445.6M | $364.5M | $386.1M | $364.2M | $370.3M | $320.6M | $320.1M |
| Net income | $8.3M | -$36.1M | $107.5M | $21.1M | $17.1M | $14.5M | $1.8M | -$249.8M |
| EPS (diluted) | $0.17 | -$0.73 | $2.14 | $0.43 | $0.34 | $0.29 | $0.04 | -$5.14 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $141.6M | $108.1M | $118.6M | $111.7M | $80.3M |
| Capital expenditure | -$68.6M | -$59.1M | -$58.5M | -$41.6M | -$34.3M |
| Free cash flow | $73.0M | $49.0M | $60.1M | $70.2M | $46.0M |
| Dividends paid | -$76.3M | -$77.0M | -$77.6M | -$11.9M | -$11.8M |
| Net share buybacks | -$80.4M | -$70.0M | -$8.4M | -$2.1M | -$22.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $189.6M
- Total assets
- $1.12B
- Total liabilities
- $578.8M
- Total debt
- $263.7M
- Net debt
- $74.1M
- Shareholders’ equity
- $542.7M
As of Jun 30, 2026 (filed Aug 10, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 28, 2026 | $0.06 | Sep 9, 2026 |
| May 29, 2026 | $0.06 | Jun 10, 2026 |
| Feb 27, 2026 | $0.06 | Mar 11, 2026 |
| Nov 28, 2025 | $0.06 | Dec 10, 2025 |
| Aug 29, 2025 | $0.06 | Sep 10, 2025 |
| May 30, 2025 | $0.06 | Jun 11, 2025 |
| Feb 24, 2025 | $0.06 | Mar 5, 2025 |
| Nov 29, 2024 | $0.06 | Dec 11, 2024 |
Short interest
- Shares sold short
- 4,767,898
- Days to cover
- 8.85
- Change vs previous report
- +5.4%
FINRA short interest, settlement date Sep 15, 2026.